Recombinant PDCD1 (Pembrolizumab Biosimilar) 抗体
Research Grade
适用: 人
ELISA
宿主: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原 See all PDCD1 (Pembrolizumab Biosimilar) products
- PDCD1 (Pembrolizumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Mammalian Cells
-
克隆类型
- 单克隆
-
标记
- This PDCD1 (Pembrolizumab Biosimilar) antibody is un-conjugated
-
应用范围
- ELISA
- 原理
- Pembrolizumab Biosimilar - Anti-PD1 mAb
- 产品特性
- Antibody Type: IgG4
- 质量等级
- Research Grade
- 亚型
- IgG4
-
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS pH 7.5
- 储存条件
- 4 °C,-20 °C
- 储存方法
- 4°C for short term, -20°C for long term
-
- 抗原
- PDCD1 (Pembrolizumab Biosimilar)
- Abstract
- PDCD1 (Pembrolizumab Biosimilar) 产品
- 物质类
- Biosimilar
- 背景
-
Pembrolizumab
Pembrolizumab is a humanized (from mouse) monoclonal antibody that binds to, and blocks PD-1 located on lymphocytes. It is an anticancer medication used in the treatment of melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, urothelial cancer (cancer of the bladder and urinary tract) and renal cell carcinoma (kidney cancer).
-
You are here:
